The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology
The facility features 2,176 high-performance GPUs across the US and Europe
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
Under the deal, Vivtex will license select oral drug-delivery technologies to Novo Nordisk
The program offers selected participants advanced access to Promise Bio’s broad-epiproteomic platform
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
